Bhutan vs Guinea-Bissau: Access to anti-retroviral drugs, male
Bhutan
62.0%
in 2024
Guinea-Bissau
62.0%
in 2024
Bhutan rank
94th
Guinea-Bissau rank
94th
Access to anti-retroviral drugs, male over time
- Bhutan
- Guinea-Bissau
How they compare
Bhutan currently reports 62.0% against 62.0% in Guinea-Bissau, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Guinea-Bissau ahead.
Bhutan ranks 94th and Guinea-Bissau ranks 94th of 141 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.9% | 2.0% | 0.9% | Bhutan |
| 2010s | 33.6% | 19.4% | 14.2% | Bhutan |
| 2020s | 58.0% | 48.0% | 10.0% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bhutan or Guinea-Bissau?
- Bhutan, at 62.0% against 62.0% in Guinea-Bissau as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bhutan and Guinea-Bissau?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Guinea-Bissau?
- 25 years are reported by both, from 2000 to 2024.
- How do Bhutan and Guinea-Bissau rank globally for access to anti-retroviral drugs, male?
- Bhutan ranks 94th and Guinea-Bissau ranks 94th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.